Duaklir® Pressair® (aclidinium/formoterol fumarate) – New drug approval
March 29, 2019 - The FDA approved AstraZeneca’s Duaklir Pressair (aclidinium/formoterol fumarate), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Download PDF
